Ann Traynor

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease

Yu Oyama, Robert M. Craig, Ann Traynor et al. · Gastroenterology · 2005 · 275 citations · Full text

Cell Therapy, Transplantation, Autoimmune Disease +8

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

Ann Traynor, James Schroeder, Robert M. Rosa et al. · The Lancet · 2000 · 244 citations

Rheumatology, Cell Therapy, Transplantation +12

Treatment of Autoimmune Disease by Intense Immunosuppressive Conditioning and Autologous Hematopoietic Stem Cell Transplantation

Richard K. Burt, Ann Traynor, Richard M. Pope et al. · Blood · 1998 · 211 citations

Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation–based conditioning regimen to prevent disease progression in patients with high disability scores

Richard K. Burt, Bruce A. Cohen, Eric J. Russell et al. · Blood · 2003 · 206 citations · Full text